About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 36 record(s)
Req # A-2022-09231
Copies of all PMPRB Board minutes and materials (briefing materials, presentations, staff recommendations) pertaining to the October 2022 revised draft Guidelines.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09622
All correspondence and emails from the federal Health Minister Jean-Yves Duclos to the Patented Medicines Prices Review Board in the period between October 1, 2022 and December 5, 2022 regarding new draft guidelines and the consultation process and all responses to the federal Minister of Health and Health Canada from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2021-10765
Copies of all expense claims and receipts over $ 100.00 for Douglas Clark, Tanya Potashnik and Mitchell Levine. For each expense provide the name of the service provider/contractor, a description of the product or service rendered, the date, and the total amount of the expense. When those three items can not be provided in said format, provide the entirety of records (including receipts, purchase orders, and service contracts) pertaining to the expense.Organization: Patented Medicine Prices Review Board Canada
April 2022
Req # A-2021-10768
Copies of all communications between the PMPRB and Health Canada from May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2022
Req # A-2021-10771
Copies of all emails or logs of media requests or contacts with the PMPRB and Douglas Clark between May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2022
Req # A-2020-18439
Copies of all email exchanges between the PMPRB and pCPA and CADTH members in the provincial offices from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10646
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Boehringer Ingelheim over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2021-10666
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2020-03991
Copies of all records, analysis, correspondence, discussions, briefings, memos and decisions, about the development of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, and EX-all levels. Also include the Minister and Political staff; between January 2016 to February 2020.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2020-03992
Copies of all analysis, correspondence, discussions, briefings and memos about the evaluation of stakeholder submissions for the PMPRB regulations (including submissions relating to the 2016 PMPRB guidelines modernization, the 2017 consultations on potential changes to the PMPRB regulations, Canada Gazette Part I, and Canada Gazette Part II) involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, EX-all levels. Include the Minister and Political staff; between January 2016 to February 2020.Organization: Patented Medicine Prices Review Board Canada
April 2021